Accelerated partial breast irradiation: Past, present, and future

Anne W. Tann, Sandra S. Hatch, Melissa M. Joyner, Lee R. Wiederhold, Todd A. Swanson

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations


Accelerated partial breast irradiation (APBI) focuses higher doses of radiation during a shorter interval to the lumpectomy cavity, in the setting of breast conserving therapy for early stage breast cancer. The utilization of APBI has increased in the past decade because of the shorter treatment schedule and a growing body of outcome data showing positive cosmetic outcomes and high local control rates in selected patients undergoing breast conserving therapy. Technological advances in various APBI modalities, including intracavitary and interstitial brachytherapy, intraoperative radiation therapy, and external beam radiation therapy, have made APBI more accessible in the community. Results of early APBI trials served as the basis for the current consensus guidelines, and multiple prospective randomized clinical trials are currently ongoing. The pending long term results of these trials will help us identify optimal candidates that can benefit from ABPI. Here we provide an overview of the clinical and cosmetic outcomes of various APBI techniques and review the current guidelines for selecting suitable breast cancer patients. We also discuss the impact of APBI on the economics of cancer care and patient reported quality of life.

Original languageEnglish (US)
Pages (from-to)370-379
Number of pages10
JournalWorld Journal of Clinical Oncology
Issue number5
StatePublished - Oct 10 2016


  • Accelerated partial breast irradiation
  • Breast cancer
  • Interstitial brachytherapy
  • Intracavitary brachytherapy

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Accelerated partial breast irradiation: Past, present, and future'. Together they form a unique fingerprint.

Cite this